What one share of Wave Life Sciences holds
We are a clinical-stage biotechnology company focused on unlocking the broad potential of ribonucleic acid (“RNA”) medicines (also known as oligonucleotides), or those targeting RNA, to transform human health. Our RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders.
Wave Life Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.35 |
|---|---|
| Profit | −$1.08 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.03 |
| Cash and investments | $1.90 |
| Book value | $2.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | −$1.90 | $0.03 | −$2.06 | — | −$4.45 |
| 2014 | — | −$1.34 | $0.15 | −$1.28 | — | $0.48 |
| 2015 | $0.01 | −$1.83 | $0.18 | −$1.37 | — | — |
| 2016 | $0.07 | −$2.44 | $0.24 | −$1.64 | — | $5.73 |
| 2017 | $0.14 | −$3.85 | $0.71 | −$3.87 | — | $5.02 |
| 2018 | $0.50 | −$5.06 | $0.34 | −$1.13 | — | $2.49 |
| 2019 | $0.47 | −$5.72 | $0.12 | −$5.67 | — | $1.86 |
| 2020 | $0.51 | −$3.82 | $0.03 | −$2.99 | — | $1.70 |
| 2021 | $0.79 | −$2.36 | $0.01 | −$1.73 | — | $0.54 |
| 2022 | $0.05 | −$2.05 | $0.02 | −$1.64 | — | −$0.52 |
| 2023 | $1.07 | −$0.54 | $0.01 | −$0.19 | — | $0.33 |
| 2024 | $0.78 | −$0.70 | $0.01 | −$1.10 | — | $1.37 |
| 2025 | $0.25 | −$1.21 | $0.00 | −$1.12 | — | $2.76 |
Common questions about Wave Life Sciences
How much does one share of Wave Life Sciences earn?
Over the last 12 months, Wave Life Sciences lost $1.08 for each share on $0.35 of sales.
Does Wave Life Sciences pay a dividend?
Wave Life Sciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Wave Life Sciences’s book value per share?
Wave Life Sciences’s book value is $2.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Wave Life Sciences have?
Each share of Wave Life Sciences has $1.90 of cash and investments, as of June 30, 2026.
What is Wave Life Sciences’s free cash flow per share?
−$1.03 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Wave Life Sciences bought back shares?
Wave Life Sciences’s share count rose about 9576% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.